MYX 0.22% $4.61 mayne pharma group limited

Fundamentals Are Strong, page-56

  1. 6,633 Posts.
    lightbulb Created with Sketch. 615
    Mayne owns 53% of Hedgepath, market cap US$120m, so about AU$80m is Mayne, its developing a new product (Stage3b), currently 0 return, which makes ROE look worse than it could be.
    Obviously there is potential for it to have future revenue or it wouldnt be worth that...
    Last edited by bug1: 17/07/17
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.